Price Band
₹123 - ₹130
Lot Size
1000
Issue Size
₹24.1 Cr
GMP
N/A
Subscription
437.60x
Analyzing...
IPO Schedule
1
Open
1 Dec 2025
2
Close
3 Dec 2025
3
Allotment
-
4
Listing
8 Dec 2025
About Ravelcare
Ravelcare is an SME focused on [Insert Ravelcare's Business Focus Here - e.g., manufacturing and supplying personal care products, providing healthcare services, etc.]. They operate within the [Insert Industry Sector Here] sector and cater to [Insert Target Market Here].
Key Strengths
- High Return on Equity (ROE) of 68.04% indicates strong profitability and efficient capital utilization.
- Relatively low Price-to-Earnings (P/E) ratio of 12.38 suggests the IPO is reasonably priced compared to earnings, potentially offering value to investors.
- [Insert Strength 3 - e.g., Established relationships with key suppliers or distributors]
- [Insert Strength 4 - e.g., Strong brand recognition in a niche market]
- [Insert Strength 5 - e.g., Demonstrated track record of consistent revenue growth]
Risk Factors
- •Being an SME, Ravelcare faces inherent risks associated with smaller scale operations, including limited access to capital and greater vulnerability to economic downturns.
- •The SME segment is inherently more volatile than larger, established companies, leading to potential fluctuations in share price post-IPO.
- •[Insert Risk 3 - e.g., Dependence on a limited number of key customers or suppliers]
Valuation Analysis
The IPO appears reasonably valued based on its P/E ratio, suggesting potential for appreciation. However, investors should carefully consider the risks associated with investing in an SME and conduct thorough due diligence before investing.
IPO Details
ExchangeBSE
SegmentSME
ISININE0W4D01018
Face Value₹10
Lot Size1000
Issue Size₹24.1 Cr
Key Metrics
ROE68.04%
ROCE68.32%
P/E Ratio12.38
Industry P/E20
EPS10.50
PAT Margin21.01%
Growth & Quality
ProfitableYes ✓
Subscription
Total15.50x
Documents
RHP not available
Key Dates
Open Date1 Dec 2025
Close Date3 Dec 2025
Listing8 Dec 2025